Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CMPS
COMPASS PATHWAYS PLC
NASDAQ
$13.73
▼ DOWN 6.22% (-0.91)

KEY STATISTICS

Market Cap$1.85 B
52w High$15.40
52w Low$4.40
Dividend Yield—
Frequency—
P/E-4.36
Volume2.64M
Shares Out.134.92M

COMPANY

LEADERSHIP

Kabir Kumar Nath
CHIEF EXECUTIVE
Kabir Kumar Nath

COMPENSATION 2026

Salary$0
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$0

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 18, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
156

PRICE TARGET

Target High$25.00
Target Low$13.00
Target Median$18.00
Target Consensus$18.63

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.—
NOV
3
TUE

PRICE

$13.73 ▼ DOWN 6.22% (−$0.91)
$13.75$14.00$14.259:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM13.73

About COMPASS Pathways plc

https://compasspathways.com ↗

COMPASS Pathways plc, based in London, develops psilocybin therapies like COMP360 for treatment-resistant depression and PTSD, having completed Phase IIb trials for depression.

INDUSTRY

Biotechnology

A PRODUCT COMPASS PATHWAYS PLC IS KNOWN FOR

COMP360
COMP360

COMP360 is a proprietary synthetic psilocybin in late-stage trials for treatment-resistant depression, with FDA Breakthrough Therapy status, showing promising Phase 3 results for rapid, durable relief in patients unresponsive to current treatments.

COMPETITORS

COMPETITOR
ATAI COMPARE
GHRS COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
24
LISTED HERE
14
RANKED BY POSITION SIZE
ARKG
3.26% · 4.7M
IBB
0.11% · 810.9K
PSIL
11.09% · 454.5K
DOCT.L
1.06% · 237.6K
SBIO
0.95% · 166.5K
SURI
1.81% · 114.3K
GWX
0.13% · 82.5K
HTEC
1.06% · 56.4K
BBC
0.73% · 26.0K
APIE
0.02% · 18.7K
IBBQ
0.12% · 8.3K
BIB
0.06% · 4.8K
ESIM
0.13% · 2.0K
TNXT
0.06% · 794

INSTITUTIONAL OWNERSHIP

SHARES OWNED
44.65%
HOLDERS
290
TOP 12 OF 290 · RANKED BY POSITION SIZE
Deep Track Capital, LP
12.2M sh · $172.09M
Rtw Investments, LP
10.7M sh · $151.42M
Bit Capital Gmbh
6.3M sh · $89.84M
Tang Capital Management LLC
5.0M sh · $70.75M
Two Sigma Investments, LP
4.5M sh · $63.26M
Marshall Wace, Llp
4.3M sh · $61.25M
Ark Investment Management LLC
3.5M sh · $48.85M
Millennium Management LLC
3.1M sh · $17.36M
Gmt Capital Corp
3.1M sh · $17.02M
Point72 Asset Management, L.P.
2.6M sh · $37.09M
Toronto Dominion Bank
2.5M sh · $17.45M
Dafna Capital Management LLC
2.4M sh · $13.38M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Shri Thanedar
Shri Thanedar
Sale (Full)
2023-01-23

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Nath Kabir
Sale · 6.0K shares
2026-08-03
★
DIRECTOR
Tregoning Kathleen
Purchase · 41.1K shares
2026-05-27
★
DIRECTOR:
Tregoning Kathleen
— · —
2026-05-27
★
DIRECTOR
Karydas Daphne
Purchase · 21.1K shares
2026-05-27

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
OUTPERFORM 3
OVERWEIGHT 1
10 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY B. Riley Securities BUY Morgan Stanley OVERWEIGHT RBC Capital OUTPERFORM Stifel BUY Evercore ISI Group OUTPERFORM Oppenheimer OUTPERFORM BTIG BUY

SECTORS PEERS

PEERPRICE
SNDA$37.46COMPARE
VREX$18.50COMPARE
FDMT$14.67COMPARE
PRTA$9.33COMPARE
CYH$2.93COMPARE
GOSS$0.17COMPARE